Inhibiting endoplasmic reticulum stress decreases tumor burden in a mouse model for hepatocellular carcinoma.
N. Pavlovic, C. Calitz, K. Thanapirom, G. Mazza, K. Rombouts, P. Gerwins, F. Heindryckx
Abstract
Hepatocellular carcinoma (HCC) is a liver tumor that arises in patients with cirrhosis. Hepatic stellate cells are key players in the progression of HCC, as they create a fibrotic micro-environment and produce growth factors and cytokines that enhance tumor cell proliferation and migration. We assessed the role of endoplasmic reticulum (ER) stress in the cross-talk between stellate cells and HCC-cells. Mice with a fibrotic HCC were treated with the IRE1-inhibitor 48C, which reduced tumor burden and collagen deposition. By co-culturing HCC-cells with stellate cells, we found that HCC-cells induce ER-stress in stellate cells, thereby contributing to their activation. Inhibiting IRE1 blocked stellate cell activation, which inhibited tumor cell proliferation and migration in different in vitro 2D and 3D co-cultures. Our results suggest that IRE1 is an important mediator in the communication between stellate cells and cancer cells and components of the ER-stress pathway may be therapeutically relevant for HCC-patients. Impact statementIRE1 is an important mediator in the communication between stellate cells and cancer cells and components of the ER-stress pathway may be therapeutically relevant for liver cancer.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Hepatic stellate cells drive hypoxia-inducible factor (HIF)-dependent metabolic rewiring and proliferation in hepatocellular carcinoma cells
Demi J. Rijlaarsdam, Jung‐Chin Chang, … Celia R. Berkers·bioRxiv·Oct 28, 2026
- Conditional deletion of CEACAM1 causes hepatic stellate cell activation
Harrison T. Muturi, Hilda E. Ghadieh, … Sonia Michael Najjar·Molecular MetabolismPeer-reviewed·Aug 19, 2024
- Follistatin-like protein 1 interacts with programmed cell death 4 to promote vascular mimicry in hepatocellular carcinoma by activating the PI3K/AKT/mTOR signaling pathway
Zhaowei Yang, Jiajing Zhu, … Hang Li·bioRxiv·Apr 30, 2025
- Intracellular XBP1-IL-24 axis dismantles cytotoxic unfolded protein response in the liver
- IL-27R signaling serves as immunological checkpoint for NK cells to promote hepatocellular carcinoma
T. Aghayev, I. O. Peshkova, … E. K. Koltsova·bioRxiv·Dec 28, 2020
- Plectin-mediated cytoskeletal crosstalk as a target for inhibition of hepatocellular carcinoma growth and metastasis.
Zuzana Outla, Gizem Oyman-Eyrilmez, … Martin Gregor·eLifePeer-reviewed·Mar 7, 2025